Cite
HARVARD Citation
Wilcox, M. et al. (2019). Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II. Open forum infectious diseases. p. . [Online].